Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp. (MDNAF)

Market Open
12 Jun, 18:42
NASDAQ NASDAQ
$
0. 31
-0
-0.3226%
$
36.43M Market Cap
- P/E Ratio
- Div Yield
17,400 Volume
- Eps
$ 0.31
Previous Close
Add Transaction
Day Range
0.3 0.32
Year Range
0.26 1.43
Want to track MDNAF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Medicenna Therapeutics Corp. logo
MDNAF Medicenna Therapeutics Corp.
13 Feb 2026
-
-
Medicenna Therapeutics Corp. logo
MDNAF Medicenna Therapeutics Corp.
14 Nov 2025
-
-
Medicenna Therapeutics Corp. logo
MDNAF Medicenna Therapeutics Corp.
25 Jun 2025
-
0.01
Medicenna Therapeutics Corp. logo
MDNAF Medicenna Therapeutics Corp.
12 Feb 2025
-
-
Medicenna Therapeutics Corp. logo
MDNAF Medicenna Therapeutics Corp.
12 Nov 2024
-
-
Medicenna Therapeutics Corp. logo
MDNAF Medicenna Therapeutics Corp.
27 Sep 2024
-
-
Medicenna Therapeutics Corp. logo
MDNAF Medicenna Therapeutics Corp.
2 Aug 2024
-
-
Medicenna Therapeutics Corp. logo
MDNAF Medicenna Therapeutics Corp.
25 Jun 2024
-
-

MDNAF Earnings Reports FAQ

What is the earnings per share (EPS) for MDNAF?

EPS data for MDNAF is currently not available, as Medicenna Therapeutics Corp has not reported recent earnings.

What is the company's earnings growth rate?

Medicenna Therapeutics Corp has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Medicenna Therapeutics Corp has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Medicenna Therapeutics Corp are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for MDNAF at this time, as Medicenna Therapeutics Corp has no recent EPS data to calculate it.